GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius AG (XTER:SRT) » Definitions » Price-to-Owner-Earnings

Sartorius AG (XTER:SRT) Price-to-Owner-Earnings : 63.90 (As of May. 05, 2024)


View and export this data going back to 1990. Start your Free Trial

What is Sartorius AG Price-to-Owner-Earnings?

As of today (2024-05-05), Sartorius AG's share price is €223.00. Sartorius AG's Owner Earnings per Share (TTM) ended in Mar. 2024 was €3.49. It's Price-to-Owner-Earnings for today is 63.90.


The historical rank and industry rank for Sartorius AG's Price-to-Owner-Earnings or its related term are showing as below:

XTER:SRT' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 31.37   Med: 112.88   Max: 2057.14
Current: 63.9

During the past 13 years, the highest Price-to-Owner-Earnings of Sartorius AG was 2057.14. The lowest was 31.37. And the median was 112.88.


XTER:SRT's Price-to-Owner-Earnings is ranked worse than
72.92% of 277 companies
in the Medical Devices & Instruments industry
Industry Median: 33.54 vs XTER:SRT: 63.90

As of today (2024-05-05), Sartorius AG's share price is €223.00. Sartorius AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was €2.17. Therefore, Sartorius AG's PE Ratio for today is 102.62.

As of today (2024-05-05), Sartorius AG's share price is €223.00. Sartorius AG's EPS without NRI for the trailing twelve months (TTM) ended in was €2.17. Therefore, Sartorius AG's PE Ratio without NRI for today is 102.62.

During the past 13 years, Sartorius AG's highest PE Ratio without NRI was 160.74. The lowest was 24.80. And the median was 54.02.


Sartorius AG Price-to-Owner-Earnings Historical Data

The historical data trend for Sartorius AG's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius AG Price-to-Owner-Earnings Chart

Sartorius AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 116.12 114.24 133.49 74.88 50.79

Sartorius AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 72.27 44.08 43.73 50.79 78.80

Competitive Comparison of Sartorius AG's Price-to-Owner-Earnings

For the Medical Instruments & Supplies subindustry, Sartorius AG's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sartorius AG's Price-to-Owner-Earnings Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sartorius AG's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Sartorius AG's Price-to-Owner-Earnings falls into.



Sartorius AG Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Sartorius AG's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=223.00/3.49
=63.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sartorius AG  (XTER:SRT) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Sartorius AG Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Sartorius AG's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Sartorius AG (XTER:SRT) Business Description

Address
Otto-Brenner-Strasse 20, Gottingen, NI, DEU, 37079
Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.